Shkreli Is a Godsend for the Drug Industry

Many argue that the bad-boy spectacle known as Martin Shkreli, the former Turing Pharmaceuticals CEO, has deeply damaged drug companies’ reputations. I would counter that he’s been more of a godsend, a human shield for the industry’s routine, abhorrent activities.